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Abstract
Background: Continuous outbreaks of the highly pathogenic H5N1 avian influenza A in Asia has
resulted in an urgent effort to improve current diagnostics to aid containment of the virus and
lower the threat of a influenza pandemic. We report here the development of a PCR-based assay
that is highly specific for the H5N1 avian influenza A virus.
Methods: A one-step reverse-transcription PCR assay was developed to detect the H5N1 avian
influenza A virus. The specificity of the assay was shown by testing sub-types of influenza A virus
and other viral and bacterial pathogens; and on field samples.
Results: Validation on 145 field specimens from Vietnam and Malaysia showed that the assay was
specific without cross reactivity to a number of other infuenza strains as well as human respiratory
related pathogens. Detection was 100% from allantoic fluid in H5N1 positive samples, suggesting it
to be a reliable sampling source for accurate detection.
Conclusion: The assay developed from this study indicates that the primers are specific for the
H5N1 influenza virus. As shown by the field tested results, this assay would be highly useful as a
diagnostic tool to help identify and control influenza epidemics.
Background
Influenza A virus infects many animals such as humans,
pigs, horses, marine mammals, and birds [1]. In avian
species, most influenza virus infections cause mild local-
ized infections of the respiratory and intestinal tract, but
highly pathogenic strains such as H5N1 cause system
infections in which mortality may reach 100% [2]. In
humans, influenza viruses cause a highly contagious acute
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respiratory disease that resulted in epidemic and pan-
demic disease in humans [3].
Three types of influenza viruses, types A, B, and C are
known and they belong to a family of single-stranded neg-
ative-sense enveloped RNA viruses called Orthomyxoviri-
dae  [4]. The viral genome is comprised of eight RNA
segments (seven in Type C). Influenza A viruses can be
classified into subtypes based on antigenic differences in
the two surface glycoproteins, namely, hemagglutinin
(HA) and neuraminidase (NA) which are required for
viral attachment and cellular release. Other major viral
proteins include the nucleoprotein (NP) which is the
main structural protein, membrane proteins (M1 and
M2), polymerase proteins (PA, PB1 and PB2), and non-
structural proteins (NS1 and NS2). Currently, sixteen sub-
types of HA (H1-H16) and nine NA (N1-N9) antigenic
variants are known in influenza A virus mostly related
with veterinary significance, with only three subtypes cir-
culating in humans (H1N1, H1N2, and H3N2). However,
in recent years, the pathogenic H5N1 subtype of avian
influenza A has been reported to cross the species barrier
and infect humans as documented in Hong Kong in 1997
and 2003 [5-7]. Since late 2003, the H5N1 avian A influ-
enza in poultry reached epidemic proportions with
reports of serious outbreaks in several Asian countries
including Vietnam, Thailand, South Korea, Laos, Cambo-
dia, Indonesia, Japan and Malaysia [8,9] that resulted in
massive culling of millions of poultry which had severe
economic repercussions.
As a result, H5N1 avian influenza A virus represents a
potential danger to human health not only in Asia but to
the world. Therefore, in addition to containment proce-
dures, sensitive detection assays for early diagnosis are
vital to lower the chances of spread and reduce the risk of
development into an epidemic. Current methods
employed to detect H5N1 subtypes include various
polymerase chain reaction (PCR) assays [10-12,7] and
antigen tests using various fluorescence and enzyme-
linked immunoassays [9]. However, these assays are
reported to be low in specificity and sensitivity, and clini-
cally, the low sensitivity of these diagnostics may limit the
usefulness for reliable detection of influenza A (H5N1)
virus in humans [9]. Therefore, there is an urgent need for
improved, validated, sensitive diagnostic tests for rapid
and early diagnosis. In this study, we describe the devel-
opment of a nucleic acid detection test that is rapid, spe-
cific and sensitive, thus allowing greatly improved
detection of the H5N1 avian influenza A virus.
Methods
RNA isolation
Extraction of total RNA was performed following manu-
facturers' protocol from QIAamp Viral RNA Mini Kit (Qia-
gen, Germany) and TRIZOL (Invitrogen, USA) using all
necessary safety precautions. The resultant RNA was dis-
solved in 20 μl of RNase-free water.
PCR
2 μl of RNA was used in 25 μl reaction mixtures using the
One-Step reverse transcription (RT)-PCR system (Qiagen,
Germany) with H5N1 specific primers (forward primer:
5'-ACTATGAAGAATTGAAACACCT-3' and reverse primer:
5'-GCAATGAAATTTCCATTACTCTC-3'). The PCR pro-
gram was set as: 60°C for 1 min, 42°C for 10 min, 50°C
for 30 min, and 94°C for 15 min followed by 35 cycles of
94°C for 30 sec, 50°C for 30 sec, and 72°C for 1 min and
lastly followed by 72°C for 10 min. The size of this PCR
product was 456 bp and was resolved in 1.2 % agarose
gels. PCR products were sequenced directly to confirm the
identity of the products.
Results and Discussion
Establishment of a new H5N1 PCR primer set
Primers were designed at the conserved regions of the viral
HA gene which may be less likely to be affected by muta-
tional changes. This allows the detection of a broad range
of isolates and variants of the H5N1 subtype. The per-
formance of the primers was first assessed in gel-based
assays using in vitro-transcribed RNA generated by the T7
RiboMax Express in vitro transcription system (Promega,
USA). The concentration of purified transcribed RNA was
measured by RiboGreen RNA quantitation reagent (Invit-
rogen, USA) and serial dilutions of in vitro-transcribed
RNA were prepared in duplicate. A single one-step RT-PCR
was done using 2 μl of RNA in a thermal cycler as
described in Methods, and products were analyzed on
agarose gels. Non-template controls were included. The
sensitivity of the assay was found to be less than 1 × 103
copies and was able to specifically detect H5N1 RNA (Fig.
1A, lanes 2 to 11).
Specific detection of H5N1 avian influenza A
To establish the specificity of the assays for H5N1 subtype
detection, we then tested the primers on several known
strains of influenza A viruses derived from avian sources
(H3N8, H5N3, H7N3 and H9N2). Non-influenza viruses
such as Newcastle disease virus (NDV) were also included
as controls (Fig. 1B). Thirteen of other known human res-
piratory diseases caused by viruses and bacteria were also
included (Fig. 1A, lanes 12 to 17, and Table 1) as controls.
Results showed that detection was specific to H5N1 only
(Fig. 1A and 1B). As the number of actual human avian
influenza virus infected cases are extremely sparse during
this study, the inclusion of a panel of known human sam-
ples that do not contain H5N1 virus derived from patients
exhibiting "flu"-like symptoms are very helpful in demon-
strating the non cross-reactive nature of these primers. In
an effort to further investigate the specificity of this set ofBMC Infectious Diseases 2006, 6:40 http://www.biomedcentral.com/1471-2334/6/40
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primers, a panel of avian and human subtypes (H1 to
H16) of Influenza A virus was screened. Results showed
that there was reactivity only against the H5 subtypes with
this primer set and no reactivity against the other subtypes
(Fig. 2A, lanes 2 to 19). To ensure that the RNA from these
subtypes were not degraded, the matrix gene from these
samples were amplified in parallel. As expected, the 978
bp product was amplified for all the subtypes tested (Fig.
2B, lanes 22 to 36). A total of 145 field samples compris-
ing of known and suspect cases from chickens, ducks and
muscovies isolated from Vietnam and Malaysia during the
2004 to 2005 outbreak were tested for H5N1 RNA (Table
Table 1: Human specimens used as controls in one-step RT-PCR H5N1 assay
Pathogen Early disease symptoms n
Virus:
Respiratory syncytial virus (RSV) B "Flu"-like 1
Dengue 1 Fever, "Flu"-like 1
Dengue 2 Fever, "Flu"-like 1
Dengue 3 Fever, "Flu"-like 1
Dengue 4 Fever, "Flu"-like 1
Severe respiratory syndrome virus (SARS) High fever, dyspnea, malaise 2
Hepatitis B virus (HBV) "Flu"-like, malaise 6
Bacteria:
Haemophilus influenzae Fever, "Flu"-like 1
Legionella pneumopnila "Flu"-like, pneumonia 1
Klebsiella pneumoniae "Flu"-like, pneumonia 1
Streptococcus pneumoniae "Flu"-like, pneumonia 1
Mycoplasma pneumoniae "Flu"-like, malaise 1
Mycobacterium Fever, malaise, dyspnea 1
Detection of H5N1 avian influenza A virus by one-step RT-PCR Figure 1
Detection of H5N1 avian influenza A virus by one-step RT-PCR. A. Amplification of serially diluted in vitro-transcribed 
single-stranded RNA (lanes 2 to 11) measured by RiboGreen RNA quantitation reagent and H5N1 RNA extracted from allan-
toic fluid of infected egg (lane 19). The non-template control is (sterile water) illustrated as "NTC". The viral load is indicated 
by the number of copies per reaction, (lane 2) 1 × 109 copies per reaction, (lane 3) 1 × 108 copies per reaction, (lane 4) 1 × 107 
copies per reaction, (lane 5) 1 × 106 copies per reaction, (lane 6) 1 × 105 copies per reaction, (lane 7) 1 × 104 copies per reac-
tion, (lane 8) 1 × 103 copies per reaction, (lane 9) 1 × 102 copies per reaction, (lane 10) 10 copies per reaction, and (lane11) 1 
copy per reaction. Viral RNA extracted from human specimens that were previously confirmed respiratory syncytial virus 
(RSV) B (lane 12), dengue virus 1 (lane 13), dengue virus 2 (lane 14), dengue virus 3 (lane 15), dengue virus 4 (lane 16) and 
severe acute respiratory syndrome (SARS) (lane 17) were also tested as known negatives. RNA extracted from healthy individ-
ual (lane 18) was also performed. B. Specific detection of H5N1 avian influenza A virus. Reference strains of different subtypes 
of avian influenza A viruses (lanes 20 to 24), including non-influenza viruses such as Newcastle disease virus (NDV, lane 25) are 
indicated. The H5N1, H3N8, H9N2 and NDV isolates were isolated from field samples by the Veterinary Research Institute, 
Malaysia, the H5N3 and H7N5 isolates were provided by the Department of Veterinary Pathology of Tottori University, Japan. 
Negative signals from non-H5N1 isolates and the non-template control (water) are shown.
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2). Samples ranged from homogenized pooled organs
and tissues, allantoic fluid, cloacal and tracheal swabs. All
yielded positive results with 100% positive detection for
allantoic fluid, 67% for cloacal and tracheal swab, and
86% for homogenized pooled tissue and organs (Table 2)
verifying the sensitivity of this RT-PCR assay. Viral culture
isolation methods performed in eggs were used as con-
firmatory tests for all positive samples (Table 2). This var-
iation in detection could be due to the different
efficiencies in viral RNA recovery from the different sam-
ples, with allantoic fluid fractions having the highest effi-
ciency for H5N1 RNA recovery and detection among the
samples (Table 2). Optimizing the extraction protocols
may also improve the RNA recovery from other tissues.
In a separate study, the sensitivity of this H5N1 primer set
was also evaluated against the currently recommended
World Health Organization (WHO) H5 primer set. Three
different strains were used – one human archived RNA
(Human 3028, from the Vietnam 2004 outbreak) and two
freshly extracted avian strains (Avian 933 and Avian
949B). A RNA dilution series was done on the three sam-
ples from 10-1 to 10-8 (Fig. 3A, lanes 2 to 11 and lanes 15
to 32), and in all the three strains, the H5N1 primer set
described here gave 1 to 2 logs better performance when
compared to the recommended WHO primer set (Fig. 3A,
Table 3), indicating that this primer set performs well and
consistent. In addition, five positive samples from the
Vietnam set were also then tested in parallel with another
Specific detection of H5N1 avian influenza A virus from archived human and avian samples Figure 2
Specific detection of H5N1 avian influenza A virus from archived human and avian samples. A. A panel of 
archived avian and human subtypes (H1 to H16) of Influenza A virus was tested against the H5N1 primers. Viral RNA were 
extracted from H1 (lane 5, A/Duck/Victoria/23/81); H2 (lane 6, A/Singapore/1/57); H3 (lane 7, A/Sydney/5/97); H4 (lane 8, A/
Stint/Australia/1/2004); H5 (lane 9, A/Avian/L2640C); H6 (lane 10, A/Avian/WA/2727/78); H7 (lane 11, A/Chicken/Victoria/85); 
H8 (lane 12, A/Turkey/Ontario/6118/67); H9 (lane 13, A/Chicken/Malacca/4905/2003); H10 (lane 14, A/Chicken/Germany/n/
49); H11 (lane 15, A/Sandpiper/Australia/6/2004); H12 (lane 16, A/Stint/WA/574/84); H14 (lane 17, A/Mallard/Gurjev/244/82); 
H15 (lane 18, A/Avian/WA/1762/78); H16 (lane 19, A/Gull/Denmark/68110/62). Two human archived RNA samples, Human 
279 (lane 3, A/Hong Kong/279/2003) and Human 3028 (lane 4, A/Vietnam/3028/2004) were tested positive. Positive H5N1 
RNA sample from in vitro-transcribed single-stranded RNA was used (lane 2), and the non-template control (water) is shown. 
B. The same set of RNA samples were tested against the matrix gene. The 978 bp fragment was detected in all samples (lanes 
22 to 36) as shown.
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Table 2: Detection of avian influenza A H5N1 subtype from field specimens.
Sample type Source Positive by H5N1
viral isolation
Positive by RT-PCR
H5N1 primers
n
Allantoic Fluid Vietnam 100% 100% 58
Cloacal and Tracheal swab Vietnam 100% 67% 43
Homogenized Pooled tissue and organs Vietnam and Malaysia 95% 86% 44BMC Infectious Diseases 2006, 6:40 http://www.biomedcentral.com/1471-2334/6/40
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current H5 primer set and results showed that the H5N1
primers described here detected five out of five positive
H5N1 samples while the other primer set only managed
to detect three out of five (Fig. 3B), indicating that the
H5N1 primers described here are more sensitive and
could detect weak positive samples with lower viral load.
Conclusion
In conclusion, we have reported an efficient, specific and
sensitive assay that has been evaluated on field specimens
to be able to detect a wide variety of H5N1 influenza virus
isolates. Accurate and sensitive detection of viral RNA is
also strongly influenced by the sample type. The rapid
Sensitivity test against human and avian strains Figure 3
Sensitivity test against human and avian strains. A. The H5N1 primers were tested for sensitivity against the currently 
recommended WHO H5 primer set using three H5N1 strains, one human strain from stored archive RNA, and two freshly 
extracted avian strains. Human 3028 (A/Vietnam/3028/2004, lanes 3 to 11); Avian 933 (lA/Chicken/Vietnam/933/2004, lanes 15 
to 23), and Avian 949B (A/Chicken/Vietnam/949B/2004, lanes 24 to 32) are shown. Serial dilution was performed on the RNA 
samples from 10-1 to 10-8 as indicated. The 219 bp fragment amplified using the WHO H5 primer set was also performed in 
parallel as indicated. B. Sensitive detection of H5N1 avian influenza A virus. Five H5N1 samples from Vietnam that have been 
confirmed by viral isolation and RT-PCR were tested in parallel with an existing H5 primer set (lanes 67 to 71) and the H5N1 
primer set (lanes 73 to 77) described in this report. Only three out of five samples were detected by the H5 primer set (lanes 
67 to 69), while the new H5N1 primer set detected all five samples (lanes 73 to 77).
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one-step single tube reaction described here not only
reduce the detection time but also lowers the risk of cross-
contamination which has a higher probability in two-
steps RT-PCR methods. This cost effective gel-based sys-
tem has a lower limit of detection in the picogram range
which is equivalent to 1 × 103 copies, and is designed to
cater for use in the field in regions where real-time PCR
platform and equipments may not be available. Clearly,
the results would be further strengthened with the inclu-
sion of more known H5N1 influenza in archived samples
from humans, but the availability of human samples are
difficult due to the low number of human infections at
this point. However, observations from this study strongly
suggest that the primers are specific for H5N1 which can
be very useful for the early detection and monitoring of
avian influenza outbreaks.
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